Camden Property Trust, an S&P 500 residential real estate investment trust (REIT), owns and operates multifamily apartment communities concentrated in high-growth Sun Belt markets. Its quarterly results offer a closely watched read on apartment fundamentals, including occupancy, lease-rate growth, and same-property performance. This report carries added weight because the company recently completed the sale of its California portfolio, reshaping its geographic mix and temporarily pressuring revenue comparisons. From what I see, the key question is whether underlying operating performance — measured primarily through FFO — can hold up even as the top line shrinks. The results also signal how management views rental demand, new supply, and capital allocation into 2027. I also checked this using Tickeron’s AI Screener to see how CPT compares to others in the industry.
For the three months ended September 30, 2026, Camden reported FFO of $1.71 per diluted share, beating the Zacks Consensus Estimate of $1.69 by about 1.2% and roughly matching the $1.70 recorded a year earlier. FFO, a standard REIT metric, adds real estate depreciation and amortization back to net income to better reflect operating cash-generating performance.
Total revenues of $381.06 million fell short of the consensus estimate of $390.11 million, a surprise of roughly -2.3%, and declined about 3.7% from $395.68 million in the prior-year period. Within that total, rental revenue was $338.3 million, down about 3.8% year over year.
GAAP diluted earnings per share came in at $8.71, a sharp jump from $1.00 a year earlier. That figure was inflated by a large gain on the sale of operating properties — primarily the California portfolio disposition — and is not representative of recurring operating performance. Net income attributable to common shareholders rose to approximately $900.4 million, compared with $108.9 million in the same quarter last year.
Heading into the print, sentiment around CPT was mixed. The stock had underperformed the broader market through the year, losing roughly 5.1% since January while the S&P 500 advanced about 12.3%, though shares had rebounded more than 9% in the month before the release. The FFO beat at the top of guidance was a positive signal, but the revenue miss and the large one-time gain complicated the picture, since the headline EPS figure overstated core earnings power. Investors will likely focus on management's commentary regarding same-property fundamentals and the sustainability of rental demand rather than the inflated GAAP figure. The narrowing of full-year FFO guidance above the prior consensus midpoint was viewed as a constructive, if modest, sign of stability.
Looking ahead, several factors will shape how investors assess Camden's trajectory. Same-property net operating income (NOI), which measures income from a company's stabilized properties before corporate overhead, remains the single most important operating gauge. Management's full-year outlook had pointed to roughly flat same-property revenue growth and modestly higher expenses, implying slight NOI pressure near term.
Lease-rate trends are another key signal. New lease rates have been under pressure in several Sun Belt markets, while renewal rates have held up better, so the blended spread between the two will be closely watched. Occupancy levels also matter, given the wave of new apartment supply delivered in recent years across many of Camden's core markets.
Finally, capital allocation will draw attention. The California sale provided liquidity that management has partly used for acquisitions, development, and share repurchases. Investors will monitor how the company deploys remaining proceeds, its development pipeline, and its balance-sheet leverage. Interest-rate expectations and broader housing affordability dynamics could also influence apartment demand into 2027, making the company's quarterly guidance updates a focal point for the market.
In my own workflow, I frequently rely on Tickeron’s AI Screener to quickly filter residential REITs and compare technical setups across peers. It helps surface comparable names and emerging patterns without manual effort, which keeps my analysis efficient when evaluating names like CPT. The tool’s customizable filters on fundamentals and trends add a useful layer when cross-checking quarterly results against broader sector moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for CPT crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CPT as a result. In 45 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for CPT just turned positive on October 02, 2026. Looking at past instances where CPT's MACD turned positive, the stock continued to rise in 25 of 46 cases over the following month. The odds of a continued upward trend are 54%.
CPT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPT advanced for three days, in 161 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
The 10-day RSI Indicator for CPT moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 19 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 56 cases where CPT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 55%.
The 50-day moving average for CPT moved below the 200-day moving average on October 01, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
CPT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CPT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. CPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.180) is normal, around the industry mean (2.202). P/E Ratio (34.482) is within average values for comparable stocks, (18.055). Projected Growth (PEG Ratio) (3.330) is also within normal values, averaging (6.621). Dividend Yield (0.041) settles around the average of (0.229) among similar stocks. P/S Ratio (6.845) is also within normal values, averaging (5.580).
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry MediaConglomerates